Zoledronic acid inhibits TSC2-null cell tumor growth via RhoA/YAP signaling pathway in mouse models of lymphangioleiomyomatosis.
Zhao D, Wu J, Zhao Y, Shao W, Cheng Q, Shao X, Yuan X, Ye J, Gao J, Jin M, Li C, Chen X, Zhao Y, Xue B.
Zhao D, et al. Among authors: shao w, shao x.
Cancer Cell Int. 2020 Feb 10;20:46. doi: 10.1186/s12935-020-1131-4. eCollection 2020.
Cancer Cell Int. 2020.
PMID: 32063747
Free PMC article.